98%
921
2 minutes
20
Epidemic surveillance using traditional approaches is dependent on case ascertainment and is delayed. Open-source intelligence (OSINT)-based syndromic surveillance can overcome limitations of delayed surveillance and poor case ascertainment, providing early warnings to guide outbreak response. It can identify outbreaks of unknown cause for which no other global surveillance exists. Using the artificial intelligence-based OSINT early warning system EPIWATCH, we describe the global epidemiology of 310 outbreaks of unknown cause that occurred December 31, 2019-January 1, 2023. The outbreaks were associated with 75,968 reported human cases and 4,235 deaths. We identified where OSINT signaled outbreaks earlier than official sources and before diagnoses were made. We identified possible signals of known disease outbreaks with poor case ascertainment. A cause was subsequently reported for only 14% of outbreaks analyzed; the percentage was substantially lower in lower/upper-middle-income economies than high-income economies, highlighting the utility of OSINT-based syndromic surveillance for early warnings, particularly in resource-poor settings.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11845160 | PMC |
http://dx.doi.org/10.3201/eid3102.240533 | DOI Listing |
J Natl Cancer Inst
September 2025
Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA.
Purpose: Early detection of HPV-associated oropharyngeal cancer (HPV+OPSCC), the most common HPV cancer in the United States, could reduce disease-related morbidity and mortality, yet currently, there are no early detection tests. Circulating tumor HPV DNA (ctHPVDNA) is a sensitive and specific biomarker for HPV+OPSCC at diagnosis. It is unknown if ctHPVDNA is detectable prior to diagnosis, and thus it's potential as an early detection test.
View Article and Find Full Text PDFPLoS One
September 2025
University of Health and Allied Sciences, Volta Region-Ho, Ghana.
Introduction: The alarming rate of drug-resistant tuberculosis (DR-TB) globally is a threat to treatment success among positive tuberculosis (TB) cases. Studies aimed at determining the prevalence, trend of DR-TB and socio-demographic and clinical risk factors contributing to DR-TB in the four regions of Ghana are currently unknown. This study sought to determine the prevalence and trend of DR-TB, identify socio-demographic and clinical risk factors that influence DR-TB, and analyse the relationship between underweight and adverse drug reactions and treatment outcomes among DR-TB patients in four regions of Ghana.
View Article and Find Full Text PDFCancer Epidemiol Biomarkers Prev
September 2025
University of Iowa Holden Comprehensive Cancer Center, Iowa City, IA, United States.
Background: Comorbidities may affect incidence and management of cancers. The burden of comorbidities among AIAN cancer patients and survivors is unknown.
Methods: Using SEER-Medicare, we identified AIAN people aged 66+ years diagnosed with female breast, lung, and colorectal cancers (2000-2019), with at least one year of Medicare coverage prior to diagnosis.
Radiology
September 2025
Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Plc, Box 1234, New York, NY 10029.
Background The prognostic value of baseline visual emphysema scoring at low-dose CT (LDCT) in lung cancer screening cohorts is unknown. Purpose To determine whether a single visual emphysema score at LDCT is predictive of 25-year mortality from all causes, chronic obstructive pulmonary disease (COPD), and cardiovascular disease (CVD). Materials and Methods In this prospective cohort study, asymptomatic adults aged 40-85 years with a history of smoking underwent baseline LDCT screening for lung cancer between June 2000 and December 2008.
View Article and Find Full Text PDFTidsskr Nor Laegeforen
September 2025
Senter for fruktbarhet og helse, Folkehelseinstituttet, og, Institutt for global helse og samfunnsmedisin, Universitetet i Bergen.
Background: The prevalence of endometriosis and adenomyosis in the Norwegian population is unknown. The aim of this study was to report on diagnoses of endometriosis, adenomyosis and related health problems among women of reproductive age.
Material And Method: We extracted specialist healthcare records of endometriosis and adenomyosis from the Norwegian Patient Registry for women aged 15 to 49 registered in Norway's National Population Register, covering the period 1 January 2008 to 31 December 2021.